Taro Pharmaceutical Industries Ltd (TARO) reported a profit for second quarter that declined from last year.
The company's earnings came in at $23.32 million, or $0.62 per share. This compares with $45.13 million, or $1.18 per share, in last year's second quarter.
Excluding items, Taro Pharmaceutical Industries Ltd reported adjusted earnings of $24.70 million or $0.66 per share for the period.
The company's revenue for the quarter fell 7.6% to $131.99 million from $142.84 million last year.
Taro Pharmaceutical Industries Ltd earnings at a glance:
-Earnings (Q2): $24.70 Mln. vs. $45.10 Mln. last year.
-EPS (Q2): $0.66 vs. $1.18 last year.
-Revenue (Q2): $131.99 Mln vs. $142.84 Mln last year.
For comments and feedback: editorial@rttnews.com